Adam Scott Levy
CIK 1693134 · CFO and Secretary · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.15M
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$9.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | CFO and Secretary | 48,538 | $23.62 | $1.15M | -$9.06M | 16 | 2026-02-20 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Chief Business Officer | — | $2.35 | — | $0 | 1 | 2020-03-18 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Chief Business Officer | 13,040 | — | — | $51.5K | 8 | 2019-02-08 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-12 | MLYS | Sell (S) | −10,757 | -$141.4K | EDGAR |
| 2024-06-13 | MLYS | Sell (S) | −96,815 | -$1.25M | EDGAR |
| 2024-02-15 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2023-03-21 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2023-02-16 | MLYS | Buy (P) | +6,250 | $100.0K | EDGAR |
| 2023-02-13 | MLYS | Grant (A) | — | $0 | EDGAR |
| 2020-03-18 | Fresh Tracks Therapeutics, Inc. (BBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-08 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-22 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | — | — | $0 | EDGAR |
| 2018-02-22 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | — | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.